Key facts
- This page summarizes Douglas Britt's Form 4 filing for TD SYNNEX CORP (SNX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Jul 2026, 16:18.
Douglas Britt - 15 Jul 2026 Form 4 Insider Report for TD SYNNEX CORP (SNX)
- Reporting relationship
- Director
- Issuer ticker
- SNX
- Reported as of
- 15 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Jul 2026, 16:18:49 UTC
- Prior SEC filing
- 24 Jun 2026
- Next SEC filing
- 22 Sep 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Cheryl Grant, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Douglas Britt filed Form 4 for TD SYNNEX CORP (SNX) on 17 Jul 2026.
Change
- Previous filing in this sequence was filed on 24 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001330988
Primary reporting owner
Britt Douglas
- Relationship
- Director
- Address
- 16202 BAY VISTA DRIVE, CLEARWATER
- Signature
- /s/ Cheryl Grant, attorney-in-fact
- Signature date
- 17 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SNX
transaction
Common Stock
Award
- Transaction value
- Shares
- +629
- Change %
- Price
- $0.000000*
- Shares after
- 629
- Date
- 15 Jul 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares of restricted stock awarded under the 2020 Stock Incentive Plan prorated for the period of time between the director's appointment and the 2027 annual meeting of shareholders. The restricted stock vests as to 25% of the shares on the last day of each of the four fiscal quarters following the date of the grant.